Related Experiment Video

Updated: May 28, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Paediatric growth charts: how do we use them and can we use them better?

Louise Ramsden1, Andrew S Day

  • 1Department of Paediatrics, Christchurch Hospital, Christchurch, New Zealand.

Journal of Paediatrics and Child Health
|October 13, 2011
PubMed

Insights

Growth assessment for children in New Zealand acute care settings is frequently missed. This study highlights the need for improved documentation and plotting of child growth data to ensure proper nutritional status evaluation.

Area of Science:

  • Paediatric Healthcare
  • Clinical Auditing

Background:

  • Accurate measurement of growth parameters is essential for effective paediatric care.
  • Growth assessment aids in identifying potential health issues like childhood obesity and nutritional deficiencies.

Purpose of the Study:

  • To evaluate the frequency and accuracy of growth assessments in children within an acute paediatric setting.
  • To determine the rate of appropriate growth chart utilization for paediatric patients.

Main Methods:

  • Retrospective review of patient charts from the Children's Acute Assessment (CAA) unit at Christchurch Public Hospital, New Zealand.
  • Analysis of documentation for height, weight, and head circumference, and their plotting on growth charts.

Main Results:

  • Weight was documented in 95% of children's charts, while height was documented in only 5%.
  • Head circumference was not measured in any of the 103 children reviewed.
  • Growth charts were present for 27% of children, with only 7% having current measurements accurately plotted.

Conclusions:

  • Significant opportunities for assessing child nutritional status in New Zealand hospitals are being missed.
  • There is a critical need to optimize child growth assessment practices, especially given rising concerns about health inequalities and childhood obesity.
Abstract

More Related Videos

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts07:56

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts

Published on: January 29, 2018

Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable09:24

Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable

Published on: May 17, 2024

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...